Imaging Features of Intratumoral Injection of NBTXR3 for Head and Neck Squamous Cell Carcinoma Lymph Node Metastases.
Daniel Thomas GinatAditya JulooriOmar I VivarLeonard A FarberZhen GooiAri J RosenbergPublished in: Diagnostics (Basel, Switzerland) (2022)
NBTXR3 nanoparticle injection is a relatively novel radioenhancer for treatment of various cancers. CT scans following NBTXR3 injection of metastatic lymph nodes from head and neck squamous cell carcinoma were reviewed in a small series of patients. The radioenhancing appears as hyperattenuating, with a mean attenuation of the injected material of 1516 HU. The material was found to leak beyond the margins of the tumor in some cases.
Keyphrases
- lymph node
- end stage renal disease
- computed tomography
- ultrasound guided
- chronic kidney disease
- neoadjuvant chemotherapy
- small cell lung cancer
- ejection fraction
- squamous cell carcinoma
- sentinel lymph node
- prognostic factors
- high resolution
- contrast enhanced
- image quality
- patient reported outcomes
- positron emission tomography
- magnetic resonance
- mass spectrometry
- combination therapy